Lonza Clonetics primary human diseased airway cells

Monday, 11 October, 2010 | Supplied by: Lonza Australia Pty Ltd



Lonza has available a broad selection of cryopreserved primary human diseased airway cells including, bronchial epithelial, smooth muscle cells and lung fibroblasts from both COPD and asthmatic donors.

We are expanding our primary cell offering to include cryopreserved cells from diseased lung tissue. Now, you can easily access ready-to-use airway cells from donors diagnosed with COPD or asthma.

More in-depth donor information is accessible through the company’s scientific support.

All cells are tested and guaranteed to perform with existing Clonetics media kits and reagents.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

AdipoGen Life Sciences tubulin products for neurodegeneration research

AdipoGen Life Sciences offers a broad range of microtubule research solutions. This includes...

SYnAbs monoclonal antibodies

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex...

Merck VirusExpress Lentiviral Production Platform

The platform helps to overcome lentiviral production challenges and can reduce process...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd